What is the treatment for erysipelas?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Erysipelas

Penicillin is the treatment of choice for erysipelas, administered orally for uncomplicated cases (penicillin V 500 mg every 6-8 hours) or parenterally for severe cases, for 5-7 days. 1

First-Line Treatment Options

  • For uncomplicated cases, oral penicillin V 500 mg every 6-8 hours for 5-7 days is recommended as first-line treatment 1
  • Alternatively, oral amoxicillin 500 mg three times daily for 5-7 days can be used 1
  • Treatment duration of 5-7 days is as effective as a 10-day course for uncomplicated cases, provided clinical improvement is observed 1
  • For severe cases requiring hospitalization, parenteral (intravenous) penicillin is recommended 1

Alternative Treatments for Penicillin-Allergic Patients

  • Clindamycin (oral 300-450 mg three times daily or intravenous 600 mg every 8 hours) is the preferred alternative for patients with penicillin allergy 1
  • Erythromycin (250 mg four times daily) is another option, though there is risk of resistance in some streptococcal strains 1, 2
  • Vancomycin (intravenous 30 mg/kg/day in 2 divided doses) may be used for severe cases with penicillin allergy 1

Treatment Considerations

  • Erysipelas is primarily caused by streptococci, especially Streptococcus pyogenes, so antibiotic coverage should target these organisms 1
  • Blood cultures have low diagnostic yield (positive in only 3% of cases) and are generally not necessary for typical cases 1, 3
  • Consider empiric therapy for community-acquired MRSA in patients with risk factors or those who do not respond to first-line therapy 1
  • Studies show that penicillin treatment results in shorter duration of fever compared to other antibiotics (1.7 vs. 4.5 days) 4

Adjunctive Measures

  • Elevation of the affected area to promote gravity drainage of edema and inflammatory substances 1
  • Treatment of potential entry points such as athlete's foot, eczema, or trauma sites 1
  • Anticoagulation and non-steroidal anti-inflammatory agents may be used as adjunctive therapy 5
  • In uncomplicated cases, systemic corticosteroids may be considered as adjunctive treatment to accelerate symptom resolution 1

Prevention of Recurrences

  • Treat predisposing conditions (athlete's foot, venous eczema, lymphedema) 1
  • Maintain well-hydrated skin with emollients 1
  • Reduce underlying edema through elevation of the limb, compression stockings, or pneumatic pressure pumps 1
  • Prophylactic antibiotic therapy with delayed penicillin is recommended for recurrent erysipelas 6

Common Pitfalls to Avoid

  • Avoid confusing erysipelas with other forms of cellulitis or skin infections that require different treatment 1
  • Avoid prolonging antibiotic treatment beyond what is necessary for uncomplicated cases 1
  • Don't overlook potential entry portals that could lead to recurrence if left untreated 1, 6
  • Remember that erysipelas diagnosis is primarily clinical, based on the presence of an acute inflammatory plaque, often with associated fever, lymphangitis, and adenopathy 7

References

Guideline

Erisipela Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Antibiotic use in patients with erysipelas: a retrospective study.

The Israel Medical Association journal : IMAJ, 2001

Research

Analysis of epidemiology, clinical features and management of erysipelas.

International journal of dermatology, 2010

Research

[Treatment of erysipelas in Germany and Austria--results of a survey in German and Austrian dermatological clinics].

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2005

Research

[Diagnostic criteria for erysipelas].

Annales de dermatologie et de venereologie, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.